Prospects for new viral vaccines. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Prospects for new viral vaccines.

Microbiol Sci. 1987 Jul;4(7):202-5. Unique Identifier : AIDSLINE MED/91058931
Norrby E; Department of Virology, School of Medicine, Karolinska Institute,; Stockholm, Sweden.

Abstract: The records of virus vaccinology are impressive. Smallpox has been subjected to global eradication and diseases like poliomyelitis and measles have been extensively reduced in many industrialized countries. The prospects for development of new vaccines are good, and new fields of knowledge have opened up as a consequence of the introduction of revolutionary technology such as recombinant-DNA technology and the hybridoma and synthetic peptide methodology. Thus, the way ahead will involve both implementation of the effective use of available products and logistic decisions about the most appropriate technology for new immunogen products.
Keywords: Hepatitis B Virus/IMMUNOLOGY Human HIV/IMMUNOLOGY Poliovirus Vaccine, Oral/ISOLATION & PURIF Respiratory Syncytial Viruses/IMMUNOLOGY Vaccines, Synthetic/ISOLATION & PURIF Viral Hepatitis Vaccines/ISOLATION & PURIF Viral Vaccines/*ISOLATION & PURIF JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDhepatitisbvirus/immunologyhumanhiv/immunologypoliovirusvaccine,oral/isolation&purifrespiratorysyncytialviruses/immunologyvaccines,synthetic/isolation&purifviralhepatitisvaccines/isolation&purifviralvaccines/KWDisolation&purifjournalarticlereviewreview,tutorial
910330
M9130599

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .